Eye MOvement DesensItisation and Reprocessing Therapy (EMDR) for FunctIonal Neurological Disorder (FND)
NCT05455450 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2025-09-16
Summary
Functional Neurological Disorder (FND) is a problem with the functioning of the nervous system and how the brain and body send and receive signals, rather than due to neurological disease or injury. This causes a range of neurological symptoms such as seizures, shaking, weakness, and paralysis. The symptoms are associated with significant distress and disability. Treatment for FND in the United Kingdom is limited, and the evidence-base for treatment is poor, despite it being a common presentation. A psychological therapy called cognitive-behavioural therapy has been found to be beneficial, but it does not help everyone. EMDR is an effective treatment for posttraumatic stress disorder, but it can also be helpful with other conditions. There is a small amount of case study evidence that EMDR can be useful at treating FND, but proper scientific evaluation is needed.
This research aims to evaluate the possibility of delivering, and potential benefit, of EMDR for FND. If the study shows that it is feasible and potentially beneficial, a larger trial will be designed. The study will recruit 50 participants who have specific functional neurological symptoms: weakness, walking difficulties, jerks, shaking, and/or seizures from a Neuropsychiatry Service. Participants will be allocated to EMDR, and routine medical appointments, or routine medical appointments alone. Allocation will be carried out by a computer programme. Those allocated to EMDR will be offered 8-16 weekly therapy sessions, completed within 6 months, and follow-up session 1 month after therapy has ended. Participants will be able to choose whether to attend therapy in-person or via an online video conferencing platform. Participants will complete questionnaires regarding health-related functioning, FND, mental health, and healthcare utilisation. These questionnaires will be completed at the beginning, 3 months, 6 months, and 9 months.
Some participants will attend interviews about experiences of treatment.
Conditions
- Functional Neurological Symptom Disorder
Interventions
- OTHER
-
Eye movement desensitisation and reprocessing therapy
Up to 16 EMDR sessions (minimum of 8 sessions), and 1-month follow-up session, as well as attending neuropsychiatric appointments (NPC). Participants will be given the choice of attending EMDR physically face-to-face or virtually via a video-consultation platform. Sessions will normally be attended weekly, with treatment completed within 6 months. Sessions will be 60-90 minutes long. EMDR will follow the standard 8-phase protocol, with additions so that it is tailored for FND presentations. The FND-specific EMDR therapy protocol has been developed for the trial by the chief investigator.
- OTHER
-
Neuropsychiatric care
Standard medical care consisting of 1-3 30 minute appointments with neuropsychiatrist over the course of the 9-month trial period.
Sponsors & Collaborators
-
South West London and St George's Mental Health NHS Trust
lead OTHER
Principal Investigators
-
Sarah R Cope, DClinPsy · South West London & St. George's Mental Health NHS Trust
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-11-07
- Primary Completion
- 2024-08-31
- Completion
- 2025-05-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Eye Movement Desensitization and Reprocessing (EMDR) in Complex Psychotrauma
NCT04594434 ·Status: COMPLETED ·Phase: NA
-
The Neural Mechanisms of Imaginal Extinction
NCT05168592 ·Status: COMPLETED ·Phase: NA
-
Teen Brain Training (TBT)
NCT06183580 ·Status: COMPLETED ·Phase: PHASE1
-
Neurobiology of Functional Movement Disorder and Non-Epileptic Seizures
NCT00500994 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Computerised Assessment of Visual Neglect Symptoms in Peripersonal Space
NCT01740544 ·Status: TERMINATED ·Phase: NA
-
Brain Activity in People With Functional Movement Disorders
NCT00448084 ·Status: COMPLETED
-
Multimodal Neuroprognostication in Disorders of Consciousness
NCT04534777 ·Status: RECRUITING
-
Electroclinical Correlation of Anxiety
NCT05393518 ·Status: RECRUITING ·Phase: NA
-
Functional Magnetic Resonance Imaging (fMRI) During Deep Brain Stimulation (DBS) to Treat Parkinson's Disease
NCT01809613 ·Status: COMPLETED
-
Understanding Mechanisms of Synaptic Degeneration Underlying Clinical Symptoms in Patients With MDs and NDs.
NCT07234851 ·Status: ENROLLING_BY_INVITATION
-
Effect of Mindfulness-based Neurofeedback for Adolescents With Elevated Repetitive Negative Thinking
NCT07055217 ·Status: RECRUITING ·Phase: NA
-
Study of Pain Catastrophizing-2 (SPAC-2)
NCT04805190 ·Status: COMPLETED ·Phase: NA
-
Double Blind Trial of DC Polarization in FTD
NCT00117858 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Evaluation of Chronic Consciousness Disorders Using Resting-state EEG and ERP
NCT05949528 ·Status: UNKNOWN
-
Investigating Electroencephalographic Predictors of Default Mode Network Anticorrelation in Healthy Adults
NCT05592600 ·Status: COMPLETED ·Phase: NA
-
Focused Research On Neurofeedback Therapy In Eradicating Depression (FRONTIER)
NCT06557525 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Development and Validation of a Novel Functional Eye-Tracking Software Application for Neurological Disorders
NCT05212727 ·Status: TERMINATED
-
Quality Improvement and Practice Based Research in Neurology Using the EMR
NCT02670161 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Neurofeedback in Clinical High Risk
NCT06492343 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Mindfulness-based Neurofeedback to Reduce Negative Thinking in CHARMS Adolescents
NCT06901232 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
fMRI-based Neurofeedback to Relieve Drug-resistant Auditory Hallucinations
NCT04798131 ·Status: RECRUITING ·Phase: NA
-
Neurofeedback Removal of Emotional Information From Mind
NCT06460207 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Mapping Functional Networks of Brain Activity (Brain Network Activation, BNA) Based on Analysis of Evoked Response Potential (ERP) Signals for Healthy Controls Evoked Response Potential (ERP) Signals for Healthy Controls and Patients With Parkinson Disease
NCT02149498 ·Status: UNKNOWN
-
Anterior Temporal Epilepsy Neuropsychological Assessment of Faces
NCT02888925 ·Status: UNKNOWN ·Phase: NA
-
Neural Mechanisms of Sevoflurane Induced Anesthesia: an EEG fMRI Study in Healthy Volunteers
NCT02149927 ·Status: COMPLETED ·Phase: EARLY_PHASE1